FDA Announces Public Advisory Committee Meeting for Blood Products Advisory Committee

Summary

The FDA is hosting a public advisory committee meeting of the Blood Products Advisory Committee to provide advice on blood and blood-derived products, with at least one portion closed to the public, and is seeking public comments on the meeting and related issues.